|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Rajesh Krishna , Lawrence YuPublisher: Springer-Verlag New York Inc. Imprint: Springer-Verlag New York Inc. Edition: 2008 ed. Dimensions: Width: 15.50cm , Height: 2.50cm , Length: 23.50cm Weight: 0.793kg ISBN: 9780387723785ISBN 10: 0387723781 Pages: 396 Publication Date: 26 November 2007 Audience: College/higher education , Professional and scholarly , Postgraduate, Research & Scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsFrom the reviews: <p> The objective of this book is to present a ~an integrated view linking pharmaceutics and the biological consequences to drug development decision making.a (TM) It is written primarily for those who work in the pharmaceutical industry applying biopharmaceutics and pharmacokinetics, or interacting with formulation scientists. The book will also be useful for those in academic and research environments. It could be valuable for students of biopharmaceutics in undergraduate or graduate programs in pharmaceutical science, and should find a role as an innovative pharmD curriculum elective. (Joseph Boullata, Doodya (TM)s Review Service, August, 2008) "From the reviews: ""The objective of this book is to present ‘an integrated view linking pharmaceutics and the biological consequences to drug development decision making.’ It is written primarily for those who work in the pharmaceutical industry applying biopharmaceutics and pharmacokinetics, or interacting with formulation scientists. The book will also be useful for those in academic and research environments. It could be valuable for students of biopharmaceutics in undergraduate or graduate programs in pharmaceutical science, and should find a role as an innovative pharmD curriculum elective."" (Joseph Boullata, Doody’s Review Service, August, 2008)" From the reviews: ""The objective of this book is to present ‘an integrated view linking pharmaceutics and the biological consequences to drug development decision making.’ It is written primarily for those who work in the pharmaceutical industry applying biopharmaceutics and pharmacokinetics, or interacting with formulation scientists. The book will also be useful for those in academic and research environments. It could be valuable for students of biopharmaceutics in undergraduate or graduate programs in pharmaceutical science, and should find a role as an innovative pharmD curriculum elective."" (Joseph Boullata, Doody’s Review Service, August, 2008) Author InformationTab Content 6Author Website:Countries AvailableAll regions |
||||